abstract |
The invention provides carriers that improve absorption, half-life or bioavailability of therapeutic compounds. The carriers comprise focus groups that bind the Vitamin D binding protein (DBP), conjugation groups to couple the focus groups to the therapeutic compounds, and optionally scaffold portions. |